WO2008145384A1 - Inflammation and oxidative stress level assay - Google Patents
Inflammation and oxidative stress level assay Download PDFInfo
- Publication number
- WO2008145384A1 WO2008145384A1 PCT/EP2008/004323 EP2008004323W WO2008145384A1 WO 2008145384 A1 WO2008145384 A1 WO 2008145384A1 EP 2008004323 W EP2008004323 W EP 2008004323W WO 2008145384 A1 WO2008145384 A1 WO 2008145384A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivatives
- acid
- oxidative stress
- metabolites
- group
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002688506A CA2688506A1 (en) | 2007-05-31 | 2008-05-30 | Inflammation and oxidative stress level assay |
EP08758894A EP2165195A1 (en) | 2007-05-31 | 2008-05-30 | Inflammation and oxidative stress level assay |
JP2010509737A JP2010528302A (en) | 2007-05-31 | 2008-05-30 | Inflammation and oxidative stress level assay |
US12/602,471 US20100233746A1 (en) | 2007-05-31 | 2008-05-30 | Inflammation and Oxidative Stress Level Assay |
AU2008256444A AU2008256444A1 (en) | 2007-05-31 | 2008-05-30 | Inflammation and oxidative stress level assay |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92482007P | 2007-05-31 | 2007-05-31 | |
US60/924,820 | 2007-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008145384A1 true WO2008145384A1 (en) | 2008-12-04 |
Family
ID=39743112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/004323 WO2008145384A1 (en) | 2007-05-31 | 2008-05-30 | Inflammation and oxidative stress level assay |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100233746A1 (en) |
EP (1) | EP2165195A1 (en) |
JP (1) | JP2010528302A (en) |
AU (1) | AU2008256444A1 (en) |
CA (1) | CA2688506A1 (en) |
WO (1) | WO2008145384A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102269737A (en) * | 2010-06-07 | 2011-12-07 | 北京嘉事联博医药科技有限公司 | HPLC (high performance liquid chromatography) detection method of arginine ketoglutarate |
EP2459510A1 (en) * | 2009-07-29 | 2012-06-06 | Phenomenome Discoveries Inc. | Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
CN103091406A (en) * | 2011-11-04 | 2013-05-08 | 上海医药工业研究院 | Detection method of fatty acid compounds and/or sterol compounds in rape bee pollen |
CN106018640A (en) * | 2016-01-27 | 2016-10-12 | 中国药科大学 | Method for rapid screening and identification of tumor biomarkers and application |
US9855233B2 (en) | 2008-08-08 | 2018-01-02 | City Of Hope | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG |
CN109507337A (en) * | 2018-12-29 | 2019-03-22 | 上海交通大学医学院附属新华医院 | A kind of new method based on blood urine metabolite prediction Gandhi's capsule for treating diabetic nephropathy mechanism |
CN113092643A (en) * | 2021-03-31 | 2021-07-09 | 大连工业大学 | Method for detecting lipid oxygenation oxidation product |
US11179361B2 (en) | 2008-08-08 | 2021-11-23 | City Of Hope | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG |
US11835499B2 (en) | 2018-02-02 | 2023-12-05 | City Of Hope | Methods of quantifying methylglyoxal-induced nucleic acid adducts |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10161928B2 (en) | 2010-07-26 | 2018-12-25 | Wellmetris, Llc | Wellness panel |
JP5846604B2 (en) * | 2012-03-23 | 2016-01-20 | 国立研究開発法人産業技術総合研究所 | Biomarker for behavioral rhythm monitoring |
JP5986440B2 (en) * | 2012-07-05 | 2016-09-06 | 国立医薬品食品衛生研究所長 | How to predict the onset of Alzheimer's disease |
EP3009839B1 (en) * | 2013-06-14 | 2018-11-28 | Seoul National University R&DB Foundation | Method for detecting hypoxia or diagnosing hypoxia-related diseases |
US20160202272A1 (en) * | 2013-09-03 | 2016-07-14 | Wellmetris Llc | Wellness panel for companion animals |
CN109212087A (en) * | 2018-10-22 | 2019-01-15 | 嘉兴迈维代谢生物科技有限公司 | A kind of quasi-arachidonic acid substance detection method |
FR3092968B1 (en) | 2019-02-22 | 2021-05-21 | Microphyt | DIETARY SUPPLEMENT |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007003343A1 (en) * | 2005-06-30 | 2007-01-11 | Biocrates Life Sciences Ag | Apparatus and method for analyzing a metabolite profile |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891622A (en) * | 1996-09-30 | 1999-04-06 | Oxford Biomedical Research, Inc. | Assessment of oxidative stress in vivo |
US20020039594A1 (en) * | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
US6096556A (en) * | 1998-02-09 | 2000-08-01 | Washington University | Method for the determination of oxidative stress |
US6620800B1 (en) * | 1998-06-29 | 2003-09-16 | Vanderbilt University | Methods and compositions to assess oxidative brain injury |
US20030211622A1 (en) * | 1998-06-29 | 2003-11-13 | Roberts L. Jackson | Methods and compositions to assess oxidative brain injury |
WO2000045929A1 (en) * | 1999-02-08 | 2000-08-10 | Admetric Biochem Inc. | Chromatographic system with pre-detector eluent switching |
EP1495132B1 (en) * | 2002-04-17 | 2013-08-28 | The Cleveland Clinic Foundation | Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents |
JP4348452B2 (en) * | 2003-12-16 | 2009-10-21 | 独立行政法人産業技術総合研究所 | Oxidative stress marker and measurement method thereof |
US20090104705A1 (en) * | 2005-05-23 | 2009-04-23 | Jan Frederik Stevens | Ascorbic acid conjugates |
-
2008
- 2008-05-30 AU AU2008256444A patent/AU2008256444A1/en not_active Abandoned
- 2008-05-30 JP JP2010509737A patent/JP2010528302A/en active Pending
- 2008-05-30 WO PCT/EP2008/004323 patent/WO2008145384A1/en active Application Filing
- 2008-05-30 CA CA002688506A patent/CA2688506A1/en not_active Abandoned
- 2008-05-30 US US12/602,471 patent/US20100233746A1/en not_active Abandoned
- 2008-05-30 EP EP08758894A patent/EP2165195A1/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007003343A1 (en) * | 2005-06-30 | 2007-01-11 | Biocrates Life Sciences Ag | Apparatus and method for analyzing a metabolite profile |
Non-Patent Citations (3)
Title |
---|
MASOODI MOJGAN ET AL: "Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry.", RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2006, vol. 20, no. 20, 2006, pages 3023 - 3029, XP002497393, ISSN: 0951-4198 * |
See also references of EP2165195A1 * |
UNTERWURZACHER I ET AL.: "Rapid quantitation of prostaglandins and other free fatty acid metabolites in low volume samples by LC-MS/MS", 3 June 2007 (2007-06-03), XP002497395, Retrieved from the Internet <URL:http://www.biocrates.com/media/ASMS%202007.pdf> [retrieved on 20030923] * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11179361B2 (en) | 2008-08-08 | 2021-11-23 | City Of Hope | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG |
US9855233B2 (en) | 2008-08-08 | 2018-01-02 | City Of Hope | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG |
US11266618B2 (en) | 2008-08-08 | 2022-03-08 | City Of Hope | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG |
EP2459510A1 (en) * | 2009-07-29 | 2012-06-06 | Phenomenome Discoveries Inc. | Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
EP2459510A4 (en) * | 2009-07-29 | 2013-08-07 | Phenomenome Discoveries Inc | Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
CN102269737B (en) * | 2010-06-07 | 2013-01-30 | 北京嘉事联博医药科技有限公司 | HPLC (high performance liquid chromatography) detection method of arginine ketoglutarate |
CN102269737A (en) * | 2010-06-07 | 2011-12-07 | 北京嘉事联博医药科技有限公司 | HPLC (high performance liquid chromatography) detection method of arginine ketoglutarate |
CN103091406A (en) * | 2011-11-04 | 2013-05-08 | 上海医药工业研究院 | Detection method of fatty acid compounds and/or sterol compounds in rape bee pollen |
CN103091406B (en) * | 2011-11-04 | 2015-06-24 | 上海医药工业研究院 | Detection method of fatty acid compounds and/or sterol compounds in rape bee pollen |
CN106018640A (en) * | 2016-01-27 | 2016-10-12 | 中国药科大学 | Method for rapid screening and identification of tumor biomarkers and application |
US11835499B2 (en) | 2018-02-02 | 2023-12-05 | City Of Hope | Methods of quantifying methylglyoxal-induced nucleic acid adducts |
CN109507337B (en) * | 2018-12-29 | 2022-02-22 | 上海交通大学医学院附属新华医院 | Novel method for predicting mechanism of Gandi capsule for treating diabetic nephropathy based on metabolites in hematuria |
CN109507337A (en) * | 2018-12-29 | 2019-03-22 | 上海交通大学医学院附属新华医院 | A kind of new method based on blood urine metabolite prediction Gandhi's capsule for treating diabetic nephropathy mechanism |
CN113092643A (en) * | 2021-03-31 | 2021-07-09 | 大连工业大学 | Method for detecting lipid oxygenation oxidation product |
Also Published As
Publication number | Publication date |
---|---|
JP2010528302A (en) | 2010-08-19 |
CA2688506A1 (en) | 2008-12-04 |
AU2008256444A1 (en) | 2008-12-04 |
EP2165195A1 (en) | 2010-03-24 |
US20100233746A1 (en) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100233746A1 (en) | Inflammation and Oxidative Stress Level Assay | |
Bian et al. | Derivatization enhanced separation and sensitivity of long chain-free fatty acids: Application to asthma using targeted and non-targeted liquid chromatography-mass spectrometry approach | |
Sterz et al. | A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids | |
Wang et al. | Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples | |
Deems et al. | Detection and quantitation of eicosanoids via high performance liquid chromatography‐electrospray ionization‐mass spectrometry | |
Tsikas | Application of gas chromatography–mass spectrometry and gas chromatography–tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans | |
Koal et al. | Challenges in mass spectrometry based targeted metabolomics | |
Teixeira et al. | Validated method for the simultaneous determination of Δ9-THC and Δ9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography–mass spectrometry with electrospray ionization | |
Sasaki et al. | Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS | |
Roberg-Larsen et al. | Highly automated nano-LC/MS-based approach for thousand cell-scale quantification of side chain-hydroxylated oxysterols [S] | |
Chhonker et al. | Quantification of eicosanoids and their metabolites in biological matrices: a review | |
Liu et al. | Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation | |
Wang et al. | Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization | |
Qi et al. | Simultaneous analysis of fatty alcohols, fatty aldehydes, and sterols in thyroid tissues by electrospray ionization-ion mobility-mass spectrometry based on charge derivatization | |
Dahl et al. | Rapid quantitative analysis of 8-iso-prostaglandin-F2α using liquid chromatography–tandem mass spectrometry and comparison with an enzyme immunoassay method | |
Goryński et al. | Development of SPME-LC–MS method for screening of eight beta-blockers and bronchodilators in plasma and urine samples | |
Xia et al. | Quantitative profiling of eicosanoids derived from n-6 and n-3 polyunsaturated fatty acids by twin derivatization strategy combined with LC-MS/MS in patients with type 2 diabetes mellitus | |
Hu et al. | Correlation between concentrations of 8-oxo-7, 8-dihydro-2′-deoxyguanosine in urine, plasma and saliva measured by on-line solid-phase extraction LC-MS/MS | |
Martín-Venegas et al. | Rapid simultaneous analysis of cyclooxygenase, lipoxygenase and cytochrome P-450 metabolites of arachidonic and linoleic acids using high performance liquid chromatography/mass spectrometry in tandem mode | |
Prasain et al. | Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry | |
Magiera | Fast, simultaneous quantification of three novel cardiac drugs in human urine by MEPS–UHPLC–MS/MS for therapeutic drug monitoring | |
Langhorst et al. | Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry | |
Davies et al. | Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry | |
Puris et al. | A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine | |
Hsu et al. | Simultaneous detection of diagnostic biomarkers of alkaptonuria, ornithine carbamoyltransferase deficiency, and neuroblastoma disease by high-performance liquid chromatography/tandem mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08758894 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010509737 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2688506 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008256444 Country of ref document: AU |
|
REEP | Request for entry into the european phase |
Ref document number: 2008758894 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008758894 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2008256444 Country of ref document: AU Date of ref document: 20080530 Kind code of ref document: A |